ALAN TAYLOR: Open Payments
NPI 1104898352 · EDDYSTONE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 44 payments from 10 companies in 2025. Trend: 2023 $899 · 2024 $981 · 2025 $1,213
Food & beverage: $1,170Education: $43
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation | 17 | $470 |
| Novo Nordisk Inc | 7 | $219 |
| Lilly USA, LLC | 6 | $152 |
| Sequel Med Tech, LLC | 4 | $103 |
| Xeris Pharmaceuticals, Inc. | 4 | $97 |
| Amgen Inc. | 1 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Averitas Pharma Inc. | 1 | $35 |
| TOLMAR, INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: AFREZZA, Ozempic, MOUNJARO, TWIIST, RECORLEV, TEPEZZA, XTAMPZA, QUTENZA.
Industry payments across PA — which companies pay providers there.
